USP <665>, USP<1665> or BPOG Extractables and Leachables for Bioprocessing Single-Use Systems

USP <665>, USP<1665> or BPOG Extractables and Leachables for Bioprocessing Single-Use Systems

Products & Services

Information

our extractables and leachables scientists based at our GMP laboratory in Reinach, Switzerland, use stepwise risk-based approach that meets regulatory expectations and enables robust data generation. Typically, we design an extractables and leachables study and method set-up to include a comprehensive analysis of the extractables and leachables including both volatile and non-volatile compounds. The extractables study would involve multiple techniques (e.g. (HS)-GC-MS, GC-MS, LC-MS or ICP-MS) where the Analytical Evaluation Threshold analysis (AET) and study design would follow recommended industry guidelines such as the USP <665>/USP <1665> or BioPhorum Best Practices Guide for Extractables Testing of Polymeric Single-Use Components used in Biopharmaceutical Manufacturing (BPOG protocol, May 2020). Analytical Study Design and Technologies Extractions with both organic and aqueous solvent and formulation/placebo are required to establish the “picture” under the worst-case conditions. Typically, aggressive conditions are applied to extractables studies such aselevated temperatures, solvents, and exposure time, in order to force potential extractables to migrate into the solvent. Analytical screening methods to characterise extractables should be comprehensive and cover volatiles, semi-volatiles & non-volatiles organic compounds and elemental analysis for inorganic compounds such as metal impurities. Through our stepwise approach to extractable/leachable studies, the data we generate supports the assessment of potential leachables present in the final product and help you to determine whether leachable impurities are present at levels that cause safety concerns. Specialist Extractables and Leachables Expertise for Bioprocessing Single-use Systems Our experts have over 25 years’ experience in specialised analytical and toxicology assessment for extractables and leachables across many product types such as pre-filled syringes, large volume parenteral products.
Intertek213Intertek Pharmaceutical Services – Bringing Quality, Safety and Sustainability to Life. Our bespoke, purpose-built GLP / GCP / GMP laboratories have supported developers and manufacturers for over 30 years by providing bioanalytical studies and advanced characterisation programs. We have worked on multiple studies involving cell or gene therapies, mRNA, plasmid DNA based products, and other advanced modalities. Our facility has been designed to handle recombinant genomic materials for the purposes of research and compliant testing, including specialist facilities for handling Class I and Class II Biological Agents. Intertek’s innovative bio/pharmaceutical services are delivered consistently with precision, pace, and passion, enabling you, our customer, to power ahead safely. Our solutions: • Cell and virus characterisation • Virology assays • Host cell and residual plasmid DNA • Cell-based assays / potency testing • General compendial testing • GMP analysis • GCP/GLP bioanalysis • ICH stability storage and testing • Method development and validation • QC release testing • Advanced delivery technology analytical support Find out more: www.intertek.com/pharmaceutical/biopharmaceuticals/gene-therapy-characterisation Contact us today: +44 (0)116 296 1620 | pharma.services@intertek.com Follow us: www.linkedin.com/showcase/intertek-pharma  ATMP Analytical Development Services & CMC Support Presentation Request | AAV Therapies: Developing Effective Analytical Strategies for In-Depth Empty vs Full Capsid Characterization > Brochure | Cell and Gene Therapies Analytical Development Services >

Log in

See all the content and easy-to-use features by logging in or registering!